BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10688755)

  • 1. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration.
    Lin HS; Chan SY; Low KS; Shoon ML; Ho PC
    J Pharm Sci; 2000 Feb; 89(2):260-7. PubMed ID: 10688755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
    Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
    J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
    Lin HS; Leong WW; Yang JA; Lee P; Chan SY; Ho PC
    Int J Pharm; 2007 Aug; 341(1-2):238-45. PubMed ID: 17482391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
    Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration.
    Hwang SR; Lim SJ; Park JS; Kim CK
    Int J Pharm; 2004 May; 276(1-2):175-83. PubMed ID: 15113624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
    Ozpolat B; Lopez-Berestein G; Adamson P; Fu CJ; Williams AH
    J Pharm Pharm Sci; 2003; 6(2):292-301. PubMed ID: 12935441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines.
    Su J; Zhang N; Ho PC
    J Pharm Sci; 2008 Jul; 97(7):2844-53. PubMed ID: 17879972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of letrozole in male and female rats: influence of complexation with hydroxybutenyl-beta cyclodextrin.
    Wempe MF; Buchanan CM; Buchanan NL; Edgar KJ; Hanley GA; Ramsey MG; Skotty JS; Rice PJ
    J Pharm Pharmacol; 2007 Jun; 59(6):795-802. PubMed ID: 17637172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats.
    Ventura P; Panini R; Montosi G; Garuti C; Vandelli M; Brunetti G; Tauschel H; Pietrangelo A; Salvioli G
    Pharmacology; 2001 Feb; 62(2):107-12. PubMed ID: 11174081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.
    Frijlink HW; Visser J; Hefting NR; Oosting R; Meijer DK; Lerk CF
    Pharm Res; 1990 Dec; 7(12):1248-52. PubMed ID: 2095562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micellar complexes of all-trans retinoic acid with polyvinylalcohol-nicotinoyl esters as new parenteral formulations in neuroblastoma.
    Zuccari G; Bergamante V; Carosio R; Gotti R; Montaldo PG; Orienti I
    Drug Deliv; 2009 May; 16(4):189-95. PubMed ID: 19241235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutics of beta-cyclodextrin derivative-based formulations of acitretin in Sprague-Dawley rats.
    Liu X; Lin HS; Chan SY; Ho PC
    J Pharm Sci; 2004 Apr; 93(4):805-15. PubMed ID: 14999719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.
    Pitha J; Gerloczy A; Olivi A
    J Pharm Sci; 1994 Jun; 83(6):833-7. PubMed ID: 9120816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions.
    Brewster ME; Anderson WR; Meinsma D; Moreno D; Webb AI; Pablo L; Estes KS; Derendorf H; Bodor N; Sawchuk R; Cheung B; Pop E
    J Pharm Sci; 1997 Mar; 86(3):335-9. PubMed ID: 9050802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of all-trans-retinoyl-beta-D-glucuronide in Sprague-Dawley rats after single and multiple intravenous administration(s).
    Lin HS; Barua AB; Olson JA; Low KS; Chan SY; Shoon ML; Ho PC
    J Pharm Sci; 2001 Dec; 90(12):2023-31. PubMed ID: 11745761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
    Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
    Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique.
    Chen Z; Lu Y; Qi J; Wu W
    Pharm Dev Technol; 2013 Feb; 18(1):130-6. PubMed ID: 22304703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.